Intellectual Property – Biomarkers in Clinical Diagnostics
Intellectual Property (IP) drives our innovation and success in the field of clinical diagnostics. We bring value to new ideas and findings related to biomarkers, assay designs and instruments.
Our patent portfolio includes about 100 patent families directed to different biomarkers and different clinical areas such as sepsis and infectiology, including also cardiology and oncology beyond prenatal screening.
In conjunction with the portfolio management, the skilful and experienced IP team focuses on generating new patent applications, monitoring and assessment of third party patents. By conducting landscape or freedom-to-operate analysis we transform patent information into business means.
Would you like to get in touch with us? The highly dedicated IP team is looking forward to your inquiry.